CLINICAL_TRIALS
trial_result
· 2021-09-05
Clinical Trial Update: Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
Phase 2 trial update on prognostic factors for frontline fludarabine, cyclophosphamide, and rituximab (FCR) therapy in chronic lymphocytic leukemia, with comple…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-09-05